INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
UNIVERSAL NASAL DROPS (solution)

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

UNIVERSAL NASAL DROPS (solution)

COMPOSITION:
Each 1 mL contains:

Phenylephrine Hydrochloride		2,5 mg
Chlorbutol		5,0 mg
Naphazoline Nitrate		0,25 mg
Nipasept, (as Preservative)		0,15%

PHARMACOLOGICAL CLASSIFICATION:
A.16.1 Nasal Decongestants

PHARMACOLOGICAL ACTION:
Anti-Allergic and decongestant.

INDICATIONS:
For the relief of sinusitis, allergic rhinitis and hayfever.

CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients.
If any allergic reactions should occur, discontinue use and consult your doctor.

DOSAGE AND DIRECTIONS FOR USE:
Adults: Instil four drops into each nostril, every four hours.
Children over 5 years: Two drops into each nostril every four hours.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Use of this preparation over prolonged periods may result in the lessening of its efficacy, and local irritation of the nasal mucosa. It is therefore recommended that your doctor be consulted, should continuous use be necessary.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:

CONDITIONS OF REGISTRATION:

IDENTIFICATION:
Colourless solution.

PRESENTATION:
15 mL dropper bottle.

STORAGE INSTRUCTIONS:
Store in a cool, dry place below 25°C and away from light. Keep out of reach of children.

REGISTRATION NUMBER:
Reference No. H1542 ·(Wet/Act 101/1965)

NAME AND BUSINESS ADDRESS OF APPLICANT:
Universal Pharmaceuticals (Pty) Ltd,
7 Browning Street, Jeppe, Johannesburg.

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
7 February 1975.

Code UP6I
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998